BioBreach is revolutionizing blood testing! We're a pre-seed startup developing a disruptive technology that analyzes a single drop of blood for accurate chemical testing at Point of care (POC). Join us in building a future of faster diagnoses, reduced patient discomfort, and improved healthcare access. We're currently fundraising $5M - check out our one-pager and see how you can be part of the revolution! #healthcare #innovation #fundraising

BioBreach

Co-Founder

Research associate

Co-founder and Process Design

Researcher

System Engineer

Manager of Manufacturing

Antimicrobial Resistant (AMR) infections, also called the "silent pandemic" is on the rise.Infections from drug-resistant bacteria (AMR), are now a leading global killer, claiming 1.27 million lives in 2019, more than HIV/AIDS or malaria. We are entering an era when people are dying from otherwise treatable infections https://lnkd.in/dDx-GJSX A major contributor to the potency of AMR is the lack of fast, affordable and accurate diagnostic method for bacterial antibiotic sensitivity. Diagnostics of the antimicrobial susceptibility take 2–3-days to complete and as result forcing doctors all around the world to prescribe antibiotic empirically by "educated guess", with a staggering 50% error rate. Treatment of patients with incorrect medication prolongs hospitalization, promote adverse medical complications, increases medical costs and accelerate the incidence of antibiotic resistance itself. Fast, accessible, and affordable antibiotic diagnostic tests are an important missing piece in patient care. With it, physicians can prescribe effective treatmentsThe Solution: phenofAST is developing a technology that not only shorten test time and provide AST results in just 3-4 hours from culture, but also doing so at low cost for wide range of bacterial disease. Using lab automation, positive bacteria samples are analyzed in a disposable cassette format containing multiple instances of antibiotic types and concentrations.The Technology: phenofAST's technology is based on label-free laser diffraction phenomena and detects bacterial cells directly, without the need for expensive and unstable molecular transducers, biochemical or metabolic reactions used elsewhere, making our test not only fast but affordable.The Value proposition: •	Faster diagnostic outcome•	Comprehensive and affordable method for broad antimicrobial challenges•	Preventing inappropriate treatment complications •	Shortening hospital length of stay•	Reducing healthcare costs across all stakeholders

phenofAST

Board Member

Chief Executive Officer

External Director

Country Manager

Diagnostics, Bioscience products & Business Development Director

Country Manager for Abbott Diagnostics & Abbott Molecular  Israel

Co-founder, and Business Development Manager at Rimipharm Inc.

Applied Spectral Imaging (ASI) improves patient care through advanced image analysis.Founded in 1993, ASI is a global leader in the development of imaging and analysis platforms for pathology, cytogenetics, and life science research.ASI's GenASIs™ automated imaging platforms for pathology and genetic analysis provide advanced diagnostic aids for pathologists and cytogeneticists, with reproducible and reliable results. The GenASIs platform can be used with most brightfield or fluorescence microscope systems and supports manual and automatic scanning for a wide range of workflows and applications, to best suit the needs, size and budget of any lab.Our GenASIs HyperSpectral™ and HiSKY® platform created the field of hyperspectral karyotyping (SKY) and is still recognized today as the field's most advanced and productive platform.ASI's applications are US FDA cleared for BandView® (karyotyping), FISHView, SpotScan (for CEP XY, UroVysion®, ALK and HER2/neu FISH), and HiPath (for IHC Family: HER2, ER, PR and Ki67).ASI maintains comprehensive patent portfolios in the US, Europe, Japan and other countries.With thousands of Systems deployed worldwide, offices in the US, Europe and Asia, and a network of over 50 distributors, ASI also takes great pride in our outstanding record of service and support. We stand ready to answer your questions and assist you at all times.

Nadav Ben-Dov

Co-Founder at BioBreach

Nadav Ben-Dov's Professional Contact Details

Nadav Ben-Dov's Current Company Details

BioBreach

Nadav Ben-Dov's Work History and Education

Frequently Asked Questions about Nadav Ben-Dov

What company does Nadav Ben-Dov work for?

What is Nadav Ben-Dov's role at BioBreach?

What is Nadav Ben-Dov's email address?

What is Nadav Ben-Dov's business email address?

What industry does Nadav Ben-Dov work in?

Prospect on LinkedIn

People Search

Company Search

Erik Straub

Michael Transon

Ready to try it out?